Webinar announcement. “Parenthood in Pharma: Strategies for Thriving before, during and after Leave”
We are pleased to invite you to our next webinar of the “Grow with the Experts” series on 17 March […]
We are pleased to invite you to our next webinar of the “Grow with the Experts” series on 17 March […]
The WMA’s Declaration of Taipei (DoT), now in the revision process, is important for patients and the public as it […]
On January 28, IFAPP Young Professionals working group invites you to join this webinar. More info at https://ifapp.org/working-group/young-professionals/
The webinar will be given by Todor Darakchiev, M. Pharm., Head of Division Medical Devices Department, Market Supervision and Inspections, […]
Regulation (EU) 2024/1689, commonly referred to as the “EU AI Act,” is considered the world’s first comprehensive regulation of artificial […]
Join us for an insightful webinar exploring the evolving professional identity within Pharmaceutical Medicine and medicines development. More information at […]
The 2024 revision of the Declaration of Helsinki included the Declaration of Taipei (DoT) for the secondary use of data […]
Practical challenges of implementing ICH-GCP(R3) in your clinical trials Please note that this webinar, a special virtual Workshop following the […]